Concepedia

Frank Schäper

FS

37

Publications

7.4K

Citations

27

H-Index

1996

Active since

Affiliations

Technische Universität Dresden(Current)

Dementia Australia

Charité - Universitätsmedizin Berlin

The University of Western Australia

St Vincent's Health

Frank Schäper is an author at Technische Universität Dresden specializing in medicine, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

1996–2022

37

Publications

37

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Acarbose Slows Progression of Intima-Media Thickness of the Carotid Arteries in Subjects With Impaired Glucose Tolerance

M Hanefeld, Jean Louis Chiasson, Carsta Koehler et al. · Stroke · 2004 · 254 citations · Full text

Insulin Secretion and Insulin Sensitivity Pattern Is Different in Isolated Impaired Glucose Tolerance and Impaired Fasting Glucose

M Hanefeld, Carsta Koehler, Katja Fuecker et al. · Diabetes Care · 2003 · 240 citations · Full text

Rows per page

1–5 of 37